In The Press

The following are recent articles, interviews, and information products in the national and global popular media that either cover my research or for which I have served as a contributor:


  1. FDA Commissioner Shares Agency’s Top Priorities at BWH Forum. BWH Bulletin. November 4, 2016.
  2. Boodman E, Ross C. Anti-Vaccine Rant Exposes Conflict Over Hospitals’ Embrace of Alternative Medicine. STAT News. January 9, 2017.
  3. Ault A. Cleveland Clinic Wellness Doctor Backs Off Antivaccine Column. Medscape Medical News. January 9, 2017.
  4. Young M. The 21st Century Cures Act Easily Passed, But is it Good for Research Protection? IRB Advisor. January 17, 2017.
  5. Celia D. Payer Roundtable: The 21st Century Cures Act. First Report Managed Care. January 23, 2017.
  6. Furlow B. Industry Payments Influence Research, Prescribing, and Advocacy. Cancer Therapy Advisor. March 9, 2017.
  7. American Medical Association (AMA) Wire profile – Dr. Sinha: The moment I knew medicine was my calling. May 8, 2017.
  8. Celia D. Health Care Reform: What Can Payers Expect from Washington? First Report Managed Care. June 9, 2017.
  9. Singer LE, Hutchinson E, et al. Letter: Professors Call Health Bills a ‘Giant Step Backward.’ The New York Times. June 23, 2017.
  10. Appold K. The 21st Century Cures Act. ENTtoday. August 15, 2017.
  11. Dodge JT. Determinants of Market Exclusivity for Prescription Drugs in the United States. The Commonwealth Fund. September 13, 2017.
  12. Massachusetts Medical Society. 2017 Interim Meeting Special Edition. Vital Signs This Week. December 4, 2017.
  13. Celia D. Health Reform Remains Unclear Heading Into 2018, Cover Story Part 1. First Report Managed Care. December 20, 2017.
  14. Celia D. What Should Payers Do To Prepare for 2018, Cover Story Part 2. First Report Managed Care. December 21, 2017.
  15. Mezher M. New Study Looks at FDA's Use of Social Media to Communicate on Drug Safety. Regulatory Focus. January 9, 2018.
  16. Budryk Z. Study: FDA Should Increase Social Media Use to Issue Safety Information. FDA News. January 10, 2018.
  17. Mukherjee S. FDA communications in the social media era. Fortune. January 11, 2018.
  18. Young, PD. Government should actively use SNS to spread information on drug safety – US researchers use FDA social media analysis. Medi:Gate News. January 16, 2018.
  19. Ross D. KIRO Radio/Seattle Morning News Interview: What the President can and cannot do to affect drug prices. March 7, 2018.
  20. Ross D. No wonder prescription drug prices aren’t cheaper yet. KIRO Radio. March 19, 2018.
  21. Kalter L. Docs: Medicare failing addicted seniors. Boston Herald. April 26, 2018.
  22. Wilcox M. Is Social Media Useful in Understanding Side Effects? MedShadow. May 7, 2018.
  23. Brennan Z. Off-Label Promotion: Are FDA’s Rules About to Unravel? Regulatory Focus. May 8, 2018.
  24. Silverman E. Tennessee becomes the second state to pass a law allowing pharma to promote off-label uses. STAT News. May 10, 2018.
  25. Goth B. Will States Push for Drug Promotion for ‘Off-Label’ Uses? Bloomberg Law. May 11, 2018.
  26. Young KD. New Efforts Taking Root to Ease Off-Label Drug Promotion. Medscape Medical News. May 15, 2018.
  27. Ross D. KIRO Radio/Seattle Morning News Interview: The government’s inability, or disinterest, regarding lowering drug prices. May 15, 2018.
  28. Dorman S. Harvard Hospital Wanted To Be More Diverse, So It Removed Portraits Of White Male ‘Luminaries.’ IJR. June 15, 2018.
  29. Kirkner RM. Trying to Sidestep Off-Label Dance-Around. Managed Care July 2, 2018.
  30. McDonald A. Female Physicians ‘Do Not Work As Hard,’ Male Doctor Tells Medical Journal. Huffington Post. September 2, 2018.
  31. Berrington L, Pedrotty J. Massachusetts Physicians Push the AMA to Lead on Gender Pay Equity. Massachusetts Medical Society Vital Signs. September 2018.
  32. She Leads Healthcare. White Paper: Ending Gender Workforce Disparities is an Ethical Imperative. September 17, 2018.
  33. Brennan Z. Researchers Point to R&D Treaty to Spur New Infectious Disease Treatments. Regulatory Focus. September 24, 2018.
  34. Brennan Z. Do the Rewards of Pediatric Exclusivity Outweigh the Benefits? Researchers Discuss. Regulatory Focus. September 26, 2018.
  35. Silverman E. A grand bargain or a bad deal? Pharma runs pediatric trials to win incentives, but consumers pay a price. STAT News. September 26, 2018.
  36. Frellick M. The True Costs of Pivotal Trials That Support FDA Approval. Medscape. October 1, 2018.
  37. Costs of pivotal trials and paediatric trials high in USA. PharmacoEconomics & Outcomes News. 813(1):7. October 6, 2018.
  38. Kronemyer B. The state of off-label drug laws. Dermatology Times. October 12, 2018.
  39. Noonan E. The Why, How, Pros, and Cons of Online Physician Communities. Massachusetts Medical Society Vital Signs. October 2018.
  40. Hamm N. Doctor Says She Was Racially Profiled on Delta Flight. NBC 10 Boston and NECN. November 1, 2018.
  41. Hauser C. ‘Are You Actually an M.D.?’: A Black Doctor Is Questioned as She Intervenes on a Delta Flight. The New York Times. November 2, 2018.
  42. Hwang K. ‘Are you really a doctor?’: Physician on flight says she was racially profiled. Indianapolis Star. November 2, 2018.
  43. Basu T. ‘Stay In Your Lane’: After California Shooting, Doctors Hit Back at NRA for Trying to Silence Them Over Guns. The Daily Beast. November 8, 2018.
  44. Karlin-Smith S, Owermohle S. Are we paying too much for pediatric drug trials? POLITICO Prescription Pulse. November 12, 2018.
  45. Silver JK. Ethical leaders: use science to advance gender equity in medicine. STAT News. November 13, 2018.
  46. Kacik A. Federal investigation finds holes in orphan drug approval process. Modern Healthcare. December 4, 2018.
  47. Dawson M. Insider trading: What it is and how to avoid it. Medical Economics. January 15, 2019.
  48. Mazzolini C. ACP 2019: Contract negotiation: What physicians need to know. April 11, 2019.
  49. Twachtman G. How to incorporate the gender wage gap into contract negotiations. MD Edge Neurology. April 19, 2019. (also published in ACP Internist, a print publication of the American College of Physicians).
  50. Gardner J. Biopharma happily takes the tax cuts, but the jobs are harder to find. Biopharma Dive. May 9, 2019.
  51. Burgess A. Faculty behind Ed Portal’s FDA course give panel discussion. The Harvard Gazette May 17, 2019.
  52. American Medical Women’s Association. AMWA Member Spotlight — Michael Sinha. August 1, 2019.
  53. Anderson J. Lincoln man's lifesaving drug rings up at $102,296 a month when insurance denies claim. Omaha World-Herald. August 24, 2019.
  54. Brigham Clinical & Research News. Look Who's Talking: Three Facts, Five Scientists. September 6, 2019.
  55. Martin N. First vaping-related death reported in Mass. The Boston Globe. October 7, 2019.­­
  56. Mercer E. Making the World a Better Place for Tomorrow’s Women In Medicine. Doximity op-(m)ed. October 8, 2019.
  57. Bartlett J. Cannabis regulators say Mass. DPH won't turn over data on problem vapes. Boston Business Journal. November 22, 2019.
  58. Dodge B. Nurse gets probation for prescribing $2.5 million worth of unnecessary fentanyl to patients for personal profit. Newsweek. November 26, 2019.
  59. Medical Economics Staff. Top Challenges Number 9: Negotiating better contracts. Medical Economics. December 19, 2019.
  60. Dodge B. Can Trump Lower the Price of Insulin and EpiPens Without Congress? Newsweek. January 17, 2020.
  61. Kaiser Family Foundation Daily Global Health Policy Report. Opinion Pieces Discuss Novel Coronavirus Outbreak. February 3, 2020.
  62. Bauman V. Pharma Pay-For-Delay Deals Called ‘Cost of Doing Business’. Bloomberg Law. February 10, 2020.
  63. Seegert L. Improving Cancer Pain Management Amid the Opioid Crisis. Cancer Therapy Advisor. March 3, 2020.
  64. Bennett C. Federal Ruling Puts Pressure on Clinical Trial Sponsors to Post Data. Cancer Therapy Advisor. March 11, 2020.
  65. Sadeque S. Panic as NY int'l dorm orders students out amid COVID-19 lockdown. Al Jazeera. March 26, 2020.
  66. Cell Press. Boston Partnership leverages local manufacturing to produce reusable face shields. AAAS EurekAlert! June 18, 2020.
  67. Collette RM. Study: Blocking Generic Drugs is a Costly and Common Pharma Tactic. Arnold Ventures. June 2, 2020.
  68. Tuccille, JD. Interstate Travel Restrictions Are Just Political Posturing. reason. June 29, 2020.
  69. Brown B, Rome B. To Cut Prescription Drug Spending, Stop Delays for Generic Competition. Petrie-Flom Bill of Health Blog. July 24, 2020.
  70. Kesselheim AS. Testimony to the House Committee on Energy and Commerce. July 29, 2020.
  71. Shieh T. Treat us as human beings not viruses. The Guam Daily Post. September 19, 2020.
  72. Thompson D. Was FDA Lax in Approving Opioids Too Easily? U.S. News & World Report / Health Day Reporter. September 30, 2020.
  73. Gardner J. Trump tax law cut what US drugmakers owed. Now they fear an increase. May 17, 2021.
  74. Newton J. A Global Search for Vaccines Fuels a Different Kind of Tourism. AFAR. May 28, 2021.
  75. Delgado C. Is It a HIPAA Violation to Ask Someone's COVID-19 Vaccination Status? VeryWell Health. June 15, 2021.